Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for branch retinal vein occlusion
2017-001179-21Phase 2Unknown
- Sponsor
- National Eye Institute
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in branch retinal vein occlusion (BRVO) comparing Minocycline with Placebo (2 arms). Primary endpoint: Mean change in best corrected visual acuity at 12 months. Status: unknown.
02
Drugs
minocycline
03
Conditions
branch retinal vein occlusion (BRVO)
Beyond the preview
Go deeper on 2017-001179-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001179-21.